Skip to main content
Top
Published in: Journal of Foot and Ankle Research 1/2022

Open Access 01-12-2022 | Review

Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis

Authors: Sean Michael Lanting, Tsz Long Chan, Sarah Louise Casey, Benjamin John Peterson, Vivienne Helaine Chuter

Published in: Journal of Foot and Ankle Research | Issue 1/2022

Login to get access

Abstract

Background

To systematically evaluate the literature investigating the relationship between cutaneous microvascular reactivity in the foot of adults with diabetes-related Charcot neuroarthropathy compared to a non-Charcot adult control group.

Methods

A systematic search was conducted to June 2021 using the biomedical databases EBSCO Megafile Ultimate, Cochrane Library and EMBASE. Original research conducting comparative investigation of cutaneous microvascular reactivity in the foot of adults with diabetes and any pattern of acute or chronic Charcot neuroarthropathy and any non-Charcot adult control groups were included. A modified Critical Appraisal Skills Programme tool was used for quality appraisal. Cutaneous microvascular reactivity in diabetes-related Charcot neuroarthropathy data were synthesised and meta-analysis conducted where possible.

Results

The search strategy identified 1,684 articles, with seven eligible for inclusion. Included studies used various methodologies and equipment to assess cutaneous microvascular reactivity in 553 participants (162 with Charcot neuroarthropathy). Cutaneous microvascular reactivity in Charcot neuroarthropathy groups was impaired compared to uncomplicated diabetes groups. Meta-analysis investigating the difference in response to thermal hyperaemia demonstrated a significant difference in cutaneous microvascular reactivity between Charcot neuroarthropathy and peripheral neuropathy with a large, pooled effect size (SMD 1.46 95% CI: 0.89–2.02) and low heterogeneity (I2 = 4%, T2= 0.01) indicating that the cutaneous microvascular response is more impaired in peripheral neuropathy than in Charcot neuroarthropathy.

Conclusions

Charcot neuroarthropathy is associated with greater cutaneous microvascular reactivity in the periphery relative to diabetes cohorts with diabetes-related peripheral neuropathy alone. It is unknown if this occurs prior to, or as a result of, Charcot neuroarthropathy.
Literature
1.
go back to reference Sanders LJ. The Charcot foot: historical perspective 1827–2003. Diabetes Metab Res. 2004;20(S1):4–8.CrossRef Sanders LJ. The Charcot foot: historical perspective 1827–2003. Diabetes Metab Res. 2004;20(S1):4–8.CrossRef
2.
go back to reference Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, et al. The Charcot foot in diabetes. J Am Podiat Med Assn. 2011;101(5):437–46.CrossRef Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, et al. The Charcot foot in diabetes. J Am Podiat Med Assn. 2011;101(5):437–46.CrossRef
3.
go back to reference Raspovic KM, Hobizal KB, Rosario BL, Wukich DK. Midfoot Charcot neuroarthropathy in patients with diabetes: the impact of foot ulceration on self-reported quality of life. Foot Ankle Spec. 2015;8(4):255–9.CrossRef Raspovic KM, Hobizal KB, Rosario BL, Wukich DK. Midfoot Charcot neuroarthropathy in patients with diabetes: the impact of foot ulceration on self-reported quality of life. Foot Ankle Spec. 2015;8(4):255–9.CrossRef
4.
go back to reference Raspovic KM, Wukich DK. Self-reported quality of life in patients with diabetes: a comparison of patients with and without Charcot neuroarthropathy. Foot Ankle Int. 2014;35(3):195–200.CrossRef Raspovic KM, Wukich DK. Self-reported quality of life in patients with diabetes: a comparison of patients with and without Charcot neuroarthropathy. Foot Ankle Int. 2014;35(3):195–200.CrossRef
5.
go back to reference Kavros SJ. Acellular fetal bovine dermal matrix for treatment of chronic ulcerations of the midfoot associated with Charcot neuroarthropathy. Foot Ankle Spec. 2012;5(4):230–4.CrossRef Kavros SJ. Acellular fetal bovine dermal matrix for treatment of chronic ulcerations of the midfoot associated with Charcot neuroarthropathy. Foot Ankle Spec. 2012;5(4):230–4.CrossRef
6.
go back to reference Gazis A, Pound N, Macfarlane R, Treece K, Game F, Jeffcoate W. Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot). Diabet Med. 2004;21(11):1243–6.CrossRef Gazis A, Pound N, Macfarlane R, Treece K, Game F, Jeffcoate W. Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot). Diabet Med. 2004;21(11):1243–6.CrossRef
7.
go back to reference Frykberg RG, Belczyk R. Epidemiology of the Charcot foot. Clin Podiatr Med Sur. 2008;25(1):17–28.CrossRef Frykberg RG, Belczyk R. Epidemiology of the Charcot foot. Clin Podiatr Med Sur. 2008;25(1):17–28.CrossRef
8.
go back to reference Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.CrossRef Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.CrossRef
9.
go back to reference Chao CY, Cheing GL. Microvascular dysfunction in diabetic foot disease and ulceration. Diabetes Metab Res Rev. 2009;25(7):604–14.CrossRef Chao CY, Cheing GL. Microvascular dysfunction in diabetic foot disease and ulceration. Diabetes Metab Res Rev. 2009;25(7):604–14.CrossRef
10.
go back to reference La Fontaine J, Lavery L, Jude E. Current concepts of Charcot foot in diabetic patients. Foot. 2016;26:7–14.CrossRef La Fontaine J, Lavery L, Jude E. Current concepts of Charcot foot in diabetic patients. Foot. 2016;26:7–14.CrossRef
11.
go back to reference Archer A, Roberts V, Watkins P. Blood flow patterns in painful diabetic neuropathy. Diabetologia. 1984;27(6):563–7.CrossRef Archer A, Roberts V, Watkins P. Blood flow patterns in painful diabetic neuropathy. Diabetologia. 1984;27(6):563–7.CrossRef
12.
go back to reference Uccioli L, Mancini L, Giordano A, Solini A, Magnani P, Manto A, et al. Lower limb arterio-venous shunts, autonomic neuropathy and diabetic foot. Diabetes Res Clin Pract. 1992;16(2):123–30.CrossRef Uccioli L, Mancini L, Giordano A, Solini A, Magnani P, Manto A, et al. Lower limb arterio-venous shunts, autonomic neuropathy and diabetic foot. Diabetes Res Clin Pract. 1992;16(2):123–30.CrossRef
13.
go back to reference Gough A, Abraha H, Li F, Purewal T, Foster A, Watkins P, et al. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med. 1997;14(7):527–31.CrossRef Gough A, Abraha H, Li F, Purewal T, Foster A, Watkins P, et al. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med. 1997;14(7):527–31.CrossRef
14.
go back to reference Edmonds M, Clarke M, Newton S, Barrett J, Watkins P. Increased uptake of bone radiopharmaceutical in diabetic neuropathy. QJM-Int J Med. 1985;57(3–4):843–55. Edmonds M, Clarke M, Newton S, Barrett J, Watkins P. Increased uptake of bone radiopharmaceutical in diabetic neuropathy. QJM-Int J Med. 1985;57(3–4):843–55.
15.
go back to reference Barwick AL, Tessier JW, de Jonge XJ, Ivers JR, Chuter VH. Peripheral sensory neuropathy is associated with altered postocclusive reactive hyperemia in the diabetic foot. BMJ Open Diabetes Res Care. 2016;4(1):e000235.CrossRef Barwick AL, Tessier JW, de Jonge XJ, Ivers JR, Chuter VH. Peripheral sensory neuropathy is associated with altered postocclusive reactive hyperemia in the diabetic foot. BMJ Open Diabetes Res Care. 2016;4(1):e000235.CrossRef
16.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–34.CrossRef Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–34.CrossRef
17.
go back to reference Hedges LV, Vevea JL. Fixed-and random-effects models in meta-analysis. Psychol Methods. 1998;3(4):486.CrossRef Hedges LV, Vevea JL. Fixed-and random-effects models in meta-analysis. Psychol Methods. 1998;3(4):486.CrossRef
18.
go back to reference Araszkiewicz A, Soska J, Borucka K, Olszewska M, Niedzwiecki P, Wierusz-Wysocka B, et al. In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process. Microvasc Res. 2015;101:143–7.CrossRef Araszkiewicz A, Soska J, Borucka K, Olszewska M, Niedzwiecki P, Wierusz-Wysocka B, et al. In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process. Microvasc Res. 2015;101:143–7.CrossRef
19.
go back to reference Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care. 2001;24(2):344–9.CrossRef Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care. 2001;24(2):344–9.CrossRef
20.
go back to reference Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. New Engl J Med. 1988;318(20):1306–9.CrossRef Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. New Engl J Med. 1988;318(20):1306–9.CrossRef
21.
go back to reference Stevens MJ, Edmonds M, Foster A, Watkins P. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia. 1992;35(2):148–54.CrossRef Stevens MJ, Edmonds M, Foster A, Watkins P. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia. 1992;35(2):148–54.CrossRef
22.
go back to reference Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998;47(3):457–63.CrossRef Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998;47(3):457–63.CrossRef
23.
go back to reference Baker N, Green A, Krishnan S, Rayman G. Microvascular and C-fiber function in diabetic Charcot neuroarthropathy and diabetic peripheral neuropathy. Diabetes Care. 2007;30(12):3077–9.CrossRef Baker N, Green A, Krishnan S, Rayman G. Microvascular and C-fiber function in diabetic Charcot neuroarthropathy and diabetic peripheral neuropathy. Diabetes Care. 2007;30(12):3077–9.CrossRef
24.
go back to reference Shapiro SA, Stansberry KB, Hill MA, Meyer MD, McNitt PM, Bhatt BA, et al. Normal blood flow response and vasomotion in the diabetic Charcot foot. J Diabetes Complicat. 1998;12(3):147–53.CrossRef Shapiro SA, Stansberry KB, Hill MA, Meyer MD, McNitt PM, Bhatt BA, et al. Normal blood flow response and vasomotion in the diabetic Charcot foot. J Diabetes Complicat. 1998;12(3):147–53.CrossRef
25.
go back to reference McCarthy I. The physiology of bone blood flow: a review. J Bone Joint Surg Am. 2006;88-A Supplement(3):4–9. McCarthy I. The physiology of bone blood flow: a review. J Bone Joint Surg Am. 2006;88-A Supplement(3):4–9.
26.
go back to reference Hoitsma E, Reulen JPH, de Baets M, Drent M, Spaans F, Faber CG. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci. 2004;227(1):119–30.CrossRef Hoitsma E, Reulen JPH, de Baets M, Drent M, Spaans F, Faber CG. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci. 2004;227(1):119–30.CrossRef
27.
go back to reference Boulton A, Scarpello J, Ward J. Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia. 1982;22(1):6–8.CrossRef Boulton A, Scarpello J, Ward J. Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia. 1982;22(1):6–8.CrossRef
28.
go back to reference Jörneskog G, Brismar K, Fagrell B. Skin capillary circulation severely impaired in toes of patients with IDDM, with and without late diabetic complications. Diabetologia. 1995;38(4):474–80.CrossRef Jörneskog G, Brismar K, Fagrell B. Skin capillary circulation severely impaired in toes of patients with IDDM, with and without late diabetic complications. Diabetologia. 1995;38(4):474–80.CrossRef
29.
go back to reference Binggeli C, Spieker LE, Corti R, Sudano I, Stojanovic V, Hayoz D, et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol. 2003;42(1):71–7.CrossRef Binggeli C, Spieker LE, Corti R, Sudano I, Stojanovic V, Hayoz D, et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol. 2003;42(1):71–7.CrossRef
30.
go back to reference Cracowski J-L, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci. 2006;27(9):503–8.CrossRef Cracowski J-L, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci. 2006;27(9):503–8.CrossRef
31.
go back to reference Yamamoto-Suganuma R, Aso Y. Relationship between post‐occlusive forearm skin reactive hyperaemia and vascular disease in patients with Type 2 diabetes—a novel index for detecting micro‐and macrovascular dysfunction using laser Doppler flowmetry. Diabet Med. 2009;26(1):83–8.CrossRef Yamamoto-Suganuma R, Aso Y. Relationship between post‐occlusive forearm skin reactive hyperaemia and vascular disease in patients with Type 2 diabetes—a novel index for detecting micro‐and macrovascular dysfunction using laser Doppler flowmetry. Diabet Med. 2009;26(1):83–8.CrossRef
Metadata
Title
Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis
Authors
Sean Michael Lanting
Tsz Long Chan
Sarah Louise Casey
Benjamin John Peterson
Vivienne Helaine Chuter
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Foot and Ankle Research / Issue 1/2022
Electronic ISSN: 1757-1146
DOI
https://doi.org/10.1186/s13047-022-00522-x

Other articles of this Issue 1/2022

Journal of Foot and Ankle Research 1/2022 Go to the issue